Objective We assessed temporal trend in the incidence and prevalence of genital warts
(GWs) in the province of Quebec, Canada, between 1998 and 2007 as a baseline for future …

Objectives Estimate the prevalence of genital warts (GW) and GW-related healthcare
resource use and costs among male and female patients seeking treatment in South Korea …

Objectives To assess the prevalence and correlates of self-reported genital warts (GWs)
among women and men aged 18–45 years in the Baltic countries. Methods In 2011–2013 …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background There has been a rapid decline in the number of young heterosexuals
diagnosed with genital warts at outpatient sexual health services since the national human …

Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …

Objectives Since the introduction of Australia's human papillomavirus vaccination program,
the management rate of genital warts in sexual health clinics and private hospitals has …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

In Québec province in Canada, a public school‐based and catch‐up HPV vaccination
programs with the quadrivalent vaccine have been introduced in September 2008 for girls …